20 AIDX
NASDAQ AIDX
$0.41 0.00 (-1.15%)
As of: Sep 29, 2026 · 3:59 PM EDT

20 (AIDX) EBITDA Margin (2025 - 2026)

Updated

20's EBITDA Margin came in at -167.60% for Q2 2026, down 13.49 percentage points from -154.11% a year earlier but up 235.78 percentage points from the prior quarter.

Analysis

20 (AIDX) EBITDA Margin (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, 20 reported EBITDA Margin of -194.36%; for FY2025, it was -158.67%, up 157.41 percentage points from FY2024.

  • Going back by year, EBITDA Margin was -316.08% in FY2024.
  • The five-year range for quarterly EBITDA Margin is -403.37% (Q1 2026) to -135.19% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 HCA Healthcare 94.29 Bn 93.74 Bn - 19.96%
2 Natera 59.14 Bn 54.82 Bn 485.19 Mn -7.25%
3 Quest Diagnostics 26.23 Bn 24.66 Bn 1.03 Bn 19.88%
4 Labcorp Holdings 25.04 Bn 22.81 Bn 1.11 Bn 16.90%
5 Guardant Health 23.69 Bn 19.76 Bn 219.03 Mn -35.69%
6 Tenet Healthcare 20.77 Bn 11.92 Bn - 30.49%
7 Tempus AI 14.91 Bn 11.94 Bn 246.50 Mn -
8 Encompass Health 12.24 Bn 12.70 Bn - 24.09%
9 Davita 11.39 Bn 10.15 Bn 1.16 Bn 21.01%
10 20 5.02 Mn -6.55 Mn 304,727.00 -167.60%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -167.60%
Mar 31, 2026 -403.37%
Jun 30, 2025 -154.11%
Mar 31, 2025 -135.19%
API Access

20 EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AIDX&period=max&api_key=YOUR_API_KEY